Clinical Significance of the NQO1 C609T Polymorphism in Non Small Cell Lung Adenocarcinoma Patients

Masroor, Mirza; Jain, Amit; Javid, Jamsheed; Mir, Rashid; Prashant, Y; Imtiyaz, A; Mariyam, Z; Mohan, Anant; Ray, PC; Saxena, Alpana

추천

검색

자료유형: 학술저널

저자정보: Masroor, Mirza (Biochemistry, Maulana Azad Medical College) Jain, Amit (Biochemistry, Maulana Azad Medical College) Javid, Jamsheed (Department of Medical Laboratory Technology, Faculty of Applied Medical Sciences, University of Tabuk) Mir, Rashid (Department of Medical Laboratory Technology, Faculty of Applied Medical Sciences, University of Tabuk) Prashant, Y (Biochemistry, Maulana Azad Medical College) Imtiyaz, A (Biochemistry, Maulana Azad Medical College) Mariyam, Z (Biochemistry, Maulana Azad Medical College) Mohan, Anant (Department of Pulmonary Medicine and Sleep Disorder All India Institute of Medical Sciences) Ray, PC (Biochemistry, Maulana Azad Medical College) Saxena, Alpana (Biochemistry, Maulana Azad Medical College)

저널정보: 아시아태평양암예방학회 Asian Pacific journal of cancer prevention : APJCP Asian Pacific journal of cancer prevention : APJCP 제16권 제17호

발행연도: 2015.1

수록면: 7,653 - 7,658 (6page)

이용수

📌

연구주제

📖

연구배경

🔬

연구방법

🏆

연구결과

초록· 키워드

오류제보하기

Background: NAD(P)H:quinone oxidoreductase 1 (NQO1) is part of the antioxidant defence system involved in detoxification. This study aimed to analyze the influence of NQO1 (C609T) genetic polymorphism in non small cell lung cancer (NSCLC)as a putative risk factor. Materials and Methods: Present study included 100 cases of NSCLC (adenocarcinoma) patients and 100 age and sex matched healthy controls. NQO1 (C609T) genotyping was performed by allele specific PCR for assessment of putative associations with clinical outcome and genotypes of. The association of the polymorphism with the survival of NSCLC patients' was analyzed by Kaplan-Meier method. Results: In Indian NSCLC (adenocarcinoma) patients increased risk of developing NSCLC was found to be associated with NQO1 609TT genotype [OR 3.68(0.90-14.98), RR 2.04(0.78-5.31)] for CT [OR 2.91(1.58-5.34), RR 1.74(1.23-2.44) p=0.0005 for CT], for CT+TT [ OR 3.26(1.82-5.82), RR 1.87(1.34-2.61) p<0.0001 for CT+TT]. A significant difference (p=0.0009) was observed in genotype distribution among cases and healthy controls. Patients with CT+TT genotype exhibited a significant poor overall survival compared with patients displaying homozygous CC genotype (p=0.03) and when survival independently compared with CC, TT and CT genotype was also found to be significantly associated (p=0.02). Overall median survival times were CT 6.0 months, TT 8.2 months, and CT + TT (6.4 months)]. Conclusions: The present study revealed that NQO1 CT, TT and CT+TT genotypes may be associated with clinical outcome and risk of developing NSCLC in the Indian population.

#NSCLC patients #adenocarcioma #NQO1 gene #C609T) polymorphism #AS-PCR

참고문헌 (0)

참고문헌 신청

참고문헌이 DBpia에서 서비스 중이라면, [참고문헌 신청]을 통해 등록해보세요

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!